Drug Shortage Report for DEXILANT

Last updated on 2021-09-15 History
Report ID 143737
Drug Identification Number 02354950
Brand name DEXILANT
Common or Proper name Dexlansoprazole delayed release capsules
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXLANSOPRAZOLE
Strength(s) 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL NASOGASTRIC ORAL NASOGASTRIC
Packaging size Bottles of 90's
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-08-05
Actual start date 2021-08-05
Estimated end date 2021-09-10
Actual end date 2021-09-14
Shortage status Resolved
Updated date 2021-09-15
Company comments
Health Canada comments
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-09-15 English Compare
v7 2021-09-14 French Compare
v6 2021-09-14 English Compare
v5 2021-08-31 French Compare
v4 2021-08-31 English Compare
v3 2021-08-06 English Compare
v2 2021-08-05 French Compare
v1 2021-08-05 English Compare